Novo Nordisk Pharmaceutical Industries, LP
H‑1B Sponsor Verified
Yes. Novo Nordisk Pharmaceutical Industries, LP filed 22 H-1B labor condition applications (LCAs) with the U.S. Department of Labor from 2022–2026, including 5 so far in 2026. The average H-1B salary is $122,580 and the most sponsored role is Validation Area Specialist - Site Capacity.
Source: U.S. Department of Labor LCA disclosure data. Most recent filing on record: May 6, 2026.
LinkedIn ↗Latest Year Filings
5
In 2026
↗ Filter by year
Total H‑1B Filings
22
Since 2020
↗ View records
Avg Annual Salary
$122,580
All years combined
↗ View chart
Top Role
Validation Area Specialist - Site …
↗ Click to filter
Filing trend
H‑1B filings by year for Novo Nordisk Pharmaceutical Industries, LP
| Year | LCA filings | Avg salary |
|---|---|---|
| 2026 | 5 | $122,987 |
| 2025 | 9 | $119,816 |
| 2024 | 4 | $131,932 |
| 2023 | 3 | $120,341 |
| 2022 | 1 | $114,736 |
Click a bar to filter records
Yearly filings & average salary · swipe to explore
SponsorStats AI
Summary